effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the lLsartan Intervention For End point reduction in hypertension Study

Autor: Olsen MH, Wachtel K, Beevers G, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe Pedersen o, Lindholm LH, Lyle PA, Mieminen MS, Omvik P, Oparil S, Wedel H., DE SIMONE, GIOVANNI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::78cbaef96f9e4b2e02f7c0a18ea96b2f
http://hdl.handle.net/11588/347155

The Anglo-Scandinavian Cardiac Outcomes Trial: Blood pressure-lowering limb (ASCOT-BPLA): effects in patients with type 2 diabetes

Autor: Ostergren, J, Sever, P, Poulter, N, Dahlof, B, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, S, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, M, OBrien, E

Publikováno v: DIABETOLOGIA. 49

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::40a4aacc627d97998963ff7f5d5d52a8
http://ora.ox.ac.uk/objects/uuid:05ccf58e-6586-4eb5-9af7-5f155888e5f6

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in patients with hypertension and left ventricular hypertrophy?:A LIFE substudy

Autor: Ibsen, H., Wachtell, K., Olsen, M.H., Borch-Johnsen, K., Lindholm, L.H., Mogensen, C.E., Dahlöf, B., Devereux, R.B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S.E., Lederballe-Pedersen, O., Nieminen, M.S., Okin, P.M., Omvik, P., Oparil, S., Wan, Y., Snapinn, S.M., Wedel, H.

Publikováno v: Ibsen, H, Wachtell, K, Olsen, M H, Borch-Johnsen, K, Lindholm, L H, Mogensen, C E, Dahlöf, B, Devereux, R B, Beevers, G, de Faire, U, Fyhrquist, F, Julius, S, Kjeldsen, S E, Lederballe-Pedersen, O, Nieminen, M S, Okin, P M, Omvik, P, Oparil, S, Wan, Y, Snapinn, S M & Wedel, H 2004, ' Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in patients with hypertension and left ventricular hypertrophy? A LIFE substudy ' J. Hypert., vol. 22, no. 9, pp. 1805-1811 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::fec2d03ba1dc552f4c2947807017f453
https://pure.au.dk/portal/da/publications/does-albuminuria-predict-cardiovascular-outcome-on-treatment-with-losartan-versus-atenolol-in-patients-with-hypertension-and-left-ventricular-hypertrophy(7c8b7c70-1b0a-11da-bee9-02004c4f4f50).html

Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Autor: Lindholm, L.H., Ibsen, H., Dahlöf, B., Devereux, R.B., Beevers, G., de Faire, U., Fyhrquest, F., Julius, S., Kjeldsen, S.E., Kristiansson, K., Lederballe-Pedersen, O., Nieminen, M.S., Omvik, P., Oparil, S., Wedel, H., Aurup, P., Edelman, J., Snapinn, S.

Publikováno v: Lindholm, L H, Ibsen, H, Dahlöf, B, Devereux, R B, Beevers, G, de Faire, U, Fyhrquest, F, Julius, S, Kjeldsen, S E, Kristiansson, K, Lederballe-Pedersen, O, Nieminen, M S, Omvik, P, Oparil, S, Wedel, H, Aurup, P, Edelman, J & Snapinn, S 2002, ' Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol ' Lancet, vol. 359, pp. 1004-1010 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::f8431078f6860bafd07b1e4dba47b1fa
https://pure.au.dk/portal/da/publications/cardiovascular-morbidity-and-mortality-in-the-losartan-intervention-for-endpoint-reduction-in-hypertension-study-life-a-randomised-trial-against-atenolol(3f7dcf20-b8d7-11da-bee9-02004c4f4f50).html

Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction. ECGs are valuable in hospital as well as general practice

Autor: Lip, G. Y., Beevers, G., Zarifis, J., Singh, S. P.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::57cab24d93b8f0e294ea6f4f7d11a9b5
https://europepmc.org/articles/PMC2350677/